SCHEMBL488964

SCHEMBL488964

OC(O)c1c2ccccc2cc2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.46
CYP1A2 P05177 5/20 0.46
HSD17B10 Q99714 4/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
HPGD P15428 3/20 0.46
KDM4E B2RXH2 3/20 0.46
GLA P06280 1/20 0.46
CYP2C19 P33261 1/20 0.46
TRPM4 Q8TD43 1/20 0.44
HIF1A Q16665 1/20 0.44
CYP1B1 Q16678 1/20 0.44
HTR2A P28223 1/20 0.43
NQO2 P16083 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MAPT P10636 2/20 0.41
POLB P06746 1/20 0.41
PKM P14618 1/20 0.41
RAD52 P43351 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL240650 0.81 UGT2B7 (0.47) ALDH1A1CYP1A2HSD17B10MEN1KMT2A
SCHEMBL13180821 0.81 HTR2A (0.45) ALDH1A1CYP1A2HSD17B10MEN1KMT2A
SCHEMBL27994398 0.81 ALDH1A1 (0.43) ALDH1A1CYP1A2HSD17B10MEN1KMT2A
SCHEMBL7560523 0.81 UGT2B7 (0.47) ALDH1A1CYP1A2HSD17B10MEN1KMT2A
SCHEMBL9051490 0.78 LMNA (0.49) ALDH1A1CYP1A2HSD17B10MEN1KMT2A
SCHEMBL2482183 0.76 ALDH1A1 (0.39) ALDH1A1CYP1A2HSD17B10MEN1KMT2A
SCHEMBL977301 0.76 ALDH1A1 (0.39) ALDH1A1CYP1A2HSD17B10MEN1KMT2A
SCHEMBL6394971 0.76 KMT2A (0.53) ALDH1A1CYP1A2HSD17B10MEN1KMT2A
SCHEMBL243405 0.76 LMNA (0.47) ALDH1A1CYP1A2HSD17B10MEN1KMT2A
SCHEMBL3075110 0.76 ALDH1A1 (0.39) ALDH1A1CYP1A2HSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8105836-B2 Chemical inhibitors of mismatch repair MORPHOTEK, INC. (US) 2012-01-31 US claimed
EP-1351565-B1 CHEMICAL INHIBITORS OF MISMATCH REPAIR MORPHOTEK INC (US) 2011-03-16 EP claimed
US-6982169-B2 Chemical inhibitors of mismatch repair MORPHOTEK, INC. (US) 2006-01-03 US claimed
EP-1351565-A4 CHEMICAL INHIBITORS OF MISMATCH REPAIR MORPHOTEK INC (US) 2005-05-25 EP claimed
EP-1417329-A4 METHODS FOR GENERATING ANTIBIOTIC RESISTANT MICROBES AND NOVEL ANTIBIOTICS MORPHOTEK INC (US) 2005-05-11 EP claimed
EP-1417329-A1 METHODS FOR GENERATING ANTIBIOTIC RESISTANT MICROBES AND NOVEL ANTIBIOTICS Morphotek Inc. (US) 2004-05-12 EP claimed
EP-1351565-A1 CHEMICAL INHIBITORS OF MISMATCH REPAIR Morphotek Inc. (US) 2003-10-15 EP claimed
US-20030143586-A1 Genetic hypermutability of plants for gene discovery and diagnosis MORPHOTEK, INC. 2003-07-31 US claimed
US-20030091997-A1 Chemical inhibitors of mismatch repair EISAI, INC. 2003-05-15 US claimed
WO-2003031937-A2 GENETIC HYPERMUTABILITY OF PLANTS FOR GENE DISCOVERY AND DIAGNOSIS MORPHOTEK, INC. (US) 2003-04-17 WO claimed
US-20030068808-A1 Methods for generating antibiotic resistant microbes and novel antibiotics MORPHOTEK, INC. 2003-04-10 US claimed
WO-2003012130-A1 METHODS FOR GENERATING ANTIBIOTIC RESISTANT MICROBES AND NOVEL ANTIBIOTICS MORPHOTEK INC. (US) 2003-02-13 WO claimed
WO-2002054856-A1 CHEMICAL INHIBITORS OF MISMATCH REPAIR MORPHOTEK INC. (US) 2002-07-18 WO claimed
EP-4091578-B1 METHOD FOR PRODUCING PLATE DENTURE TOKUYAMA DENTAL CORP (JP) 2024-10-09 EP disclosed
US-11857385-B2 Method of producing plate denture, curable composition for stereolithography, and plate denture production kit TOKUYAMA DENTAL CORPORATION (JP) 2024-01-02 US disclosed
US-20230137898-A1 METHOD OF PRODUCING PLATE DENTURE, CURABLE COMPOSITION FOR STEREOLITHOGRAPHY, AND PLATE DENTURE PRODUCTION KIT TOKUYAMA DENTAL CORPORATION (JP) 2023-05-04 US disclosed
WO-2002054856-A1 CHEMICAL INHIBITORS OF MISMATCH REPAIR MORPHOTEK INC. (US) 2002-07-18 WO disclosed
US-20020055064-A1 Anti-reflective coating composition, multilayer photoresist material using the same, and method for forming pattern TOKYO OHKA KOGYO CO., LTD. (JP) 2002-05-09 US disclosed
US-20010044080-A1 Method for forming a finely patterned photoresist layer TOKYO OHKA KOGYO CO., LTD. (JP) 2001-11-22 US disclosed
US-20010036998-A1 Anti-reflective coating-forming composition TOKYO OHKA KOGYO CO., LTD. (JP) 2001-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030091997-A1 Chemical inhibitors of mismatch repair MSH2, MSH6, PMS2 ALDH1A1 347/4885CYP1A2 2746/4885HSD17B10 2040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.